Walker J M, Beevers D G
Drugs. 1979 Oct;18(4):312-24. doi: 10.2165/00003495-197918040-00004.
In the second half of this century, morbidity and mortality from cardiovascular disease has reached epidemic proportions. The major risk factor associated with cardiovascular disease has been found, from various epidemiological studies, to be elevated blood pressure. Therefore, a lot of energy has been expended in prospective therapeutic trials in attempting to detect whether treatment of high blood pressure is beneficial. In severe hypertension, where the risk to the individual is considerable, this benefit has been demonstrated with relative ease. However, it has not yet proven possible to show conclusive benefit of treatment in the mild group of hypertensives, which form the vast majority of patients seen in general practice. A different approach has been advocated where account is taken of other coincidental cardiovascular risk factors; their presence or absence should help the clinician decide whether to treat or not to treat in the individual case.
在本世纪下半叶,心血管疾病的发病率和死亡率已达到流行程度。通过各种流行病学研究发现,与心血管疾病相关的主要危险因素是血压升高。因此,人们在前瞻性治疗试验中投入了大量精力,试图检测高血压治疗是否有益。在严重高血压中,个体面临的风险相当大,这种益处相对容易得到证明。然而,尚未证明对轻度高血压患者进行治疗有确凿益处,而轻度高血压患者占普通门诊所见患者的绝大多数。有人主张采用一种不同的方法,即考虑其他并存的心血管危险因素;这些因素的存在与否应有助于临床医生在个别病例中决定是否进行治疗。